BIOTECH: Two companies cutting 220 jobs May 27, 2009
Nanogen Inc. said it is requesting bankruptcy court approval to sell its assets for 25 ... Nanogen is laying off 89 workers, according to state data. (North County Times)
Delisting of Securities of Nanogen, Inc. From The NASDAQ Stock Market Mar 27, 2009
NEW YORK, March 26, 2009 (GLOBE NEWSWIRE) -- The NASDAQ Stock Market announced today that it will delist the common stock of Nanogen, Inc. Nanogen, Inc.'s stock was suspended on March 23, 2009, and has not traded on NASDAQ since that time. NASDAQ will file a Form 25 with the Securities and Exchange Commission to complete the delisting. (Primezone Releases)
Directed Electronics' sales shrink Mar 18, 2008
Down quarter for Nanogen. Nanogen, a San Diego company developing in-vitro diagnostics, reported a fourth-quarter loss of $6 ... Nanogen's consolidated cash, cash equivalents and short-term investments at the end of the fourth quarter of 2007 was about $7. (San Diego Union-Tribune -- Business)
Ethertronics Inc. Tops Deloitte's San Diego Technology Fast 50 Ranking of Fastest Growing Companies, With 6,603.2 Percent Revenue Growth Over Five Years Oct 13, 2007
39 San Diego 44 Nanogen, Inc. 56. 31 San Diego 45 St. Bernard Software, Inc. 53. (PR Newswire)
Local creditors to recoup some funds Sep 22, 2007
Nanogen said it would layoff 13 people from its microarray sector, or 4 percent of its total work force. The San Diego-based diagnostics maker announced Sept. 17 that it was exploring options for selling or closing its microarray business. (San Diego Union-Tribune -- Business)
Nanogen set to unload its money-losing technology Sep 19, 2007
Molecular diagnostics maker Nanogen announced yesterday that it will try to sell its 15-year-old founding technology, or close the money-losing program, as part of an aggressive plan to achieve profitability ... The microarray business is one of three business areas in which Nanogen sells products ... A small biotechnology company such as Nanogen cannot afford to continue investing in the technology as well as build a market, he said. (San Diego Union-Tribune -- Business)
New chief executive to take over for ResMed's founder Sep 2, 2007
Former Nanogen executive joined ResMed in 2003; has been head of ResMed Global since 2004 ... Gallahue, formerly at San Diego-based Nanogen, was brought in to ResMed with the thought that he would be able to take over as CEO, Farrell said. (San Diego Union-Tribune -- Business)
ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008. Aug 31, 2007
Before joining ResMed, Mr. Gallahue served as President of Nanogen, Inc., a San Diego-based DNA research and medical diagnostics company. In his earlier career, he also worked for Instrumentation Laboratory, Procter e and the General Electric Company. (PR Newswire)
Migraine trial under way Aug 29, 2007
Nanogen plans offering. Nanogen, a San Diego-based company that develops medical test products, announced a $20 million offering of unsecured senior convertible notes and warrants to fund working capital and general corporate purposes. (San Diego Union-Tribune -- Business)
Biothreat detector developed Jul 14, 2007
Nanogen Inc., a San Diego-based company developing diagnostics, said it has acquired rights to genetic markers related to schizophrenia and responses to anti-psychotic therapies from the Cooperative Research Centre for Diagnostics and Queensland University of Technology in Australia. Nanogen said it plans to use the markers to create diagnostic tests for schizophrenia and related conditions. (San Diego Union-Tribune -- Business)
Drug-test firm seeks partners Jun 21, 2007
Two recently announced alliances -- one with Nanogen Inc. and another with an undisclosed large clinical laboratory -- will help the company expand its marketing, Cipkowski said. Nanogen would package American Bio Medica's kits with its own products to sell to hospitals and physicians. (Albany Times Union)
GAO faults translation contract Jun 13, 2007
Nanogen project targets bioterror. San Diego-based Nanogen, which develops diagnostic products, said it has received funding from several Canadian agencies, including the Canadian Food Inspection Agency, to develop diagnostic tools to detect natural or potential bioterror threats to livestock. (San Diego Union-Tribune -- Business)
Nanogen Announces Collaboration with Canadian Agencies to Develop Veterinary and Bioterror Diagnostics Jun 12, 2007
SAN DIEGO, June 12 /CNW/ - Nanogen, Inc. (Nasdaq:NGEN), developer of advanced diagnostic products, announced today that it has received project funding from several Canadian agencies, including the Canadian Food Inspection Agency (CFIA) ... "Although the majority of our NanoChip(R) instruments are used in basic research and human clinical diagnostics applications, we have always known that the platform's flexibility confers benefit in other markets, such as veterinary diagnostics and the... (Canada Newswire)
Adventrx joins VA in drug studies May 26, 2007
Nanogen publicizes shelf offering. San Diego-based diagnostics maker Nanogen said it may periodically sell up to $50 million in common and preferred stock, debt securities and warrants. (San Diego Union-Tribune -- Business)
Shareholder sues Stratagene Apr 19, 2007
Nanogen seeks FDA approval. Nanogen, which develops medical test products, said it asked the Food and Drug Administration to approve its cystic fibrosis test kit and the Nanochip 400 microarray system. (San Diego Union-Tribune -- Business)
Business Tricks from Presidential Campaigns Apr 10, 2007
This time around, many candidates are taking their campaigns online in new ways. Find out how you can use their tactics to build brand loyalty and convert community interest into sales. (MSNBC -- Business)
Building Net presence Mar 17, 2007
Notable clients: Garden Fresh, Intuit, Nanogen, Centre City Development Corp., Del Mar Fairgrounds, K. Hovnanian. Red Door builds Web sites and creates e-mail newsletters for its clients. (San Diego Union-Tribune -- Business)
Medtronic reports profits up 6 percent Feb 21, 2007
Nanogen, which develops medical test products, reported a fourth-quarter loss of $11. 2 million, or 17 cents a share, compared with a loss of $69. (San Diego Union-Tribune -- Business)
Hazy future for genetic drugs, tests Jan 3, 2007
That's just the beginning, said Howard Birndorf, chief executive of Nanogen, a San Diego test company. He envisions a device that one day could instantly perform multiple tests on a person, like the tricorder used on the television series ``Star Trek. (San Jose Mercury News -- Business)
